The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

Have outer foot pain? Here are common causes of pain on the outer side of your foot, the symptoms to watch for, and how to ...

The most common joints affected include the elbows ... Pain relief and anti-inflammatories: NSAIDs (non-steroidal ...

Paracetamol and ibuprofen are two of the most commonly used and widely available painkillers in the UK, but there are certain ...

Dr. Carrie Jose, in her latest Health and Wellness column, provides the top five arthritis myths that keep people in pain.

Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.

Gastrointestinal symptoms are extremely common with NSAID therapy, as demonstrated by the fact that, in our study, the five most common adverse events leading to the discontinuation of treatment ...

Orthopedic surgeons are evaluated on patient experience through patient-focused surveys, patient-related outcome measures, ...

Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved XIFYRMtm (meloxicam injection), an IV non-steroidal anti-inflammatory drug (NSAID) that ...